205 related articles for article (PubMed ID: 25846762)
21. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
[TBL] [Abstract][Full Text] [Related]
22. All-trans retinoic acid induces COX-2 and prostaglandin E2 synthesis in SH-SY5Y human neuroblastoma cells: involvement of retinoic acid receptors and extracellular-regulated kinase 1/2.
Alique M; Herrero JF; Lucio-Cazana FJ
J Neuroinflammation; 2007 Jan; 4():1. PubMed ID: 17204142
[TBL] [Abstract][Full Text] [Related]
23. Copper-dependent toxicity in SH-SY5Y neuroblastoma cells involves mitochondrial damage.
Arciello M; Rotilio G; Rossi L
Biochem Biophys Res Commun; 2005 Feb; 327(2):454-9. PubMed ID: 15629136
[TBL] [Abstract][Full Text] [Related]
24. Combinatorial Effect of DCA and Let-7a on Triple-Negative MDA-MB-231 Cells: A Metabolic Approach of Treatment.
Sharma P; Singh S
Integr Cancer Ther; 2020; 19():1534735420911437. PubMed ID: 32248711
[TBL] [Abstract][Full Text] [Related]
25. Dichloroacetate induces apoptosis in endometrial cancer cells.
Wong JY; Huggins GS; Debidda M; Munshi NC; De Vivo I
Gynecol Oncol; 2008 Jun; 109(3):394-402. PubMed ID: 18423823
[TBL] [Abstract][Full Text] [Related]
26. Dual-targeting of aberrant glucose metabolism in glioblastoma.
Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
[TBL] [Abstract][Full Text] [Related]
27. Dichloroacetate and cancer: new home for an orphan drug?
Kankotia S; Stacpoole PW
Biochim Biophys Acta; 2014 Dec; 1846(2):617-29. PubMed ID: 25157892
[TBL] [Abstract][Full Text] [Related]
28. [Possible mechanism of the selective action of the inhibitors of glycolysis in the endothelial cells and the human carcinoma cells in the culture].
Giliano NY; Bondarev GN; Konevega LV; Noskin LA; Zhurishkina EV; Alchinova IB
Patol Fiziol Eksp Ter; 2014; (4):78-85. PubMed ID: 25980231
[TBL] [Abstract][Full Text] [Related]
29. Autophagic flux inhibition enhances cytotoxicity of the receptor tyrosine kinase inhibitor ponatinib.
Corallo D; Pastorino F; Pantile M; Mariotto E; Caicci F; Viola G; Ponzoni M; Tonini GP; Aveic S
J Exp Clin Cancer Res; 2020 Sep; 39(1):195. PubMed ID: 32962733
[TBL] [Abstract][Full Text] [Related]
30. Dichloroacetate, the Pyruvate Dehydrogenase Complex and the Modulation of mESC Pluripotency.
Rodrigues AS; Correia M; Gomes A; Pereira SL; Perestrelo T; Sousa MI; Ramalho-Santos J
PLoS One; 2015; 10(7):e0131663. PubMed ID: 26147621
[TBL] [Abstract][Full Text] [Related]
31. 6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells.
Gomez-Lazaro M; Bonekamp NA; Galindo MF; Jordán J; Schrader M
Free Radic Biol Med; 2008 Jun; 44(11):1960-9. PubMed ID: 18395527
[TBL] [Abstract][Full Text] [Related]
32. Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas.
Shen H; Yu M; Tsoli M; Chang C; Joshi S; Liu J; Ryall S; Chornenkyy Y; Siddaway R; Hawkins C; Ziegler DS
Neuro Oncol; 2020 Jan; 22(1):139-151. PubMed ID: 31398252
[TBL] [Abstract][Full Text] [Related]
33. Sensitization of breast cancer cells to paclitaxel by dichloroacetate through inhibiting autophagy.
Wang M; Liao C; Hu Y; Qinwen Pan ; Jiang J
Biochem Biophys Res Commun; 2017 Jul; 489(2):103-108. PubMed ID: 28528979
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
35. In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells.
Anderson KM; Jajeh J; Guinan P; Rubenstein M
Anticancer Res; 2009 Nov; 29(11):4579-88. PubMed ID: 20032407
[TBL] [Abstract][Full Text] [Related]
36. Targeting of two aspects of metabolism in breast cancer treatment.
Gang BP; Dilda PJ; Hogg PJ; Blackburn AC
Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950
[TBL] [Abstract][Full Text] [Related]
37. Effect of sodium dichloroacetate on apoptotic gene expression in human leukemia cell lines.
Abramek J; Bogucki J; Ziaja-Sołtys M; Stępniewski A; Bogucka-Kocka A
Pharmacol Rep; 2019 Apr; 71(2):248-256. PubMed ID: 30822618
[TBL] [Abstract][Full Text] [Related]
38. Metformin enhances cytotoxic action of dichloroacetate against Lewis lung carcinoma cells in vitro.
Kolesnik DL; Pyaskovskaya ON; Gorbach O; Solyanik GI
Exp Oncol; 2020 Mar; 42(1):35-39. PubMed ID: 32231186
[TBL] [Abstract][Full Text] [Related]
39. Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs.
Heshe D; Hoogestraat S; Brauckmann C; Karst U; Boos J; Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2011 Mar; 67(3):647-55. PubMed ID: 20502900
[TBL] [Abstract][Full Text] [Related]
40. Novel molecular mechanisms of antitumor action of dichloroacetate against T cell lymphoma: Implication of altered glucose metabolism, pH homeostasis and cell survival regulation.
Kumar A; Kant S; Singh SM
Chem Biol Interact; 2012 Jul; 199(1):29-37. PubMed ID: 22705712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
